Longwood Fund

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events
  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

ArcherDX Announces Close of $60M Financing to Advance Companion Diagnostic and Minimal Residual Disease Monitoring Product Portfolio

May 15, 2019

GRAIL Announces Significant Progress with Multi-Cancer Early Detection Test Including FDA Breakthrough Device Designation

May 13, 2019

Verastem Reports First Quarter 2019 Financial Results, $1.7M in Net Product Revenues

May 9, 2019

Bicycle Therapeutics Enters Neuroscience Arena through Collaboration with Dementia Discovery Fund

May 7, 2019

FDA Accepts Recros Medica De Novo Submission for Nuvellus Focal Contouring System

May 7, 2019

GRAIL Licenses Nasopharyngeal Cancer Early Detection Technology to TAKE2

May 6, 2019
« Older Entries
Newer Entries »

Longwood Fund

The Prudential Tower

800 Boylston Street
Suite 1715
Boston, MA, 02199

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

© Longwood Fund. All Rights Reserved